A novel antibody drug reactivates the immune defense in patients with advanced-stage cancer by altering the function of the body’s phagocytes and facilitating extensive activation of the immune system

An immunotherapeutic antibody therapy re-educates macrophages to activate passivated cytotoxic T cells to kill cancer

New study by scientists at the Cleveland Clinic finds FDA-approved medicine, bevacizumab (Avastin), potentially ineffective for glioblastoma (brain cancer) patients.

Caffeine consumption may help slow breast cancer growth